InnoCare Pharma Ltd
SSE:688428
InnoCare Pharma Ltd
SSE:688428
Price:
31.3
CNY
0.42%
Market Closed
Market Cap:
¥26.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
InnoCare Pharma Ltd
SSE:688428
|
CN |
|
S
|
Silk Road Logistics Holdings Ltd
HKEX:988
|
HK |
|
PTC Industries Ltd
BSE:539006
|
IN |
|
Indo Us Bio-Tech Ltd
BSE:541304
|
IN |
|
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
US |
|
C
|
Cubex Tubings Ltd
NSE:CUBEXTUB
|
IN |
Income Statement
Earnings Waterfall
InnoCare Pharma Ltd
InnoCare Pharma Ltd
Income Statement
InnoCare Pharma Ltd
InnoCare Pharma Ltd
Currency: CNY
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
5
|
10
|
21
|
34
|
42
|
0
|
0
|
54
|
|
| Revenue |
166
N/A
|
420
+153%
|
698
+66%
|
1 009
+45%
|
1 225
+21%
|
1 321
+8%
|
1 427
+8%
|
2 375
+66%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(27)
|
(67)
|
(109)
|
(138)
|
(169)
|
(174)
|
(186)
|
(191)
|
|
| Gross Profit |
138
N/A
|
353
+155%
|
589
+67%
|
871
+48%
|
1 055
+21%
|
1 147
+9%
|
1 241
+8%
|
2 184
+76%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(300)
|
(648)
|
(995)
|
(1 393)
|
(1 435)
|
(1 476)
|
(1 537)
|
(1 684)
|
|
| Selling, General & Administrative |
(132)
|
(243)
|
(400)
|
(585)
|
(615)
|
(675)
|
(705)
|
(761)
|
|
| Research & Development |
(178)
|
(421)
|
(615)
|
(737)
|
(844)
|
(843)
|
(876)
|
(872)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(98)
|
0
|
0
|
0
|
(102)
|
|
| Other Operating Expenses |
9
|
17
|
20
|
27
|
24
|
41
|
43
|
51
|
|
| Operating Income |
(162)
N/A
|
(295)
-82%
|
(406)
-38%
|
(522)
-28%
|
(380)
+27%
|
(330)
+13%
|
(296)
+10%
|
500
N/A
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
16
|
27
|
121
|
71
|
91
|
116
|
66
|
156
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(2)
|
0
|
(1)
|
(1)
|
0
|
|
| Pre-Tax Income |
(146)
N/A
|
(268)
-84%
|
(285)
-6%
|
(453)
-59%
|
(291)
+36%
|
(215)
+26%
|
(231)
-8%
|
656
N/A
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
(0)
|
(0)
|
(0)
|
(2)
|
(5)
|
(8)
|
(12)
|
|
| Income from Continuing Operations |
(146)
|
(268)
|
(285)
|
(453)
|
(293)
|
(221)
|
(239)
|
644
|
|
| Income to Minority Interest |
3
|
6
|
10
|
12
|
12
|
12
|
10
|
(2)
|
|
| Net Income (Common) |
(142)
N/A
|
(262)
-84%
|
(275)
-5%
|
(441)
-60%
|
(280)
+36%
|
(209)
+25%
|
(230)
-10%
|
642
N/A
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.16
-100%
|
-0.14
+12%
|
-0.26
-86%
|
-0.15
+42%
|
-0.17
-13%
|
-0.12
+29%
|
0.38
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
